Cargando…
Foamy Combinatorial Anti-HIV Vectors with MGMTP140K Potently Inhibit HIV-1 and SHIV Replication and Mediate Selection In Vivo
Highly active antiretroviral therapy (HAART) has greatly reduced the morbidity and mortality from HIV infection, but AIDS continues to be a serious health problem worldwide. Despite enormous efforts to develop a vaccine, there is still no cure, and alternative approaches including gene therapy shoul...
Autores principales: | Kiem, Hans-Peter, Wu, Robert A., Sun, Guihua, von Laer, Dorothee, Rossi, John J., Trobridge, Grant D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162371/ https://www.ncbi.nlm.nih.gov/pubmed/19741733 http://dx.doi.org/10.1038/gt.2009.118 |
Ejemplares similares
-
Foamy Virus Vectors for HIV Gene Therapy
por: Olszko, Miles E., et al.
Publicado: (2013) -
Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
por: Nalla, Arun K., et al.
Publicado: (2016) -
Large Animal Models for Foamy Virus Vector Gene Therapy
por: Trobridge, Grant D., et al.
Publicado: (2012) -
Stem Cell Selection In Vivo Using Foamy Vectors Cures Canine Pyruvate Kinase Deficiency
por: Trobridge, Grant D., et al.
Publicado: (2012) -
Correction: Stem Cell Selection In Vivo Using Foamy Vectors Cures Canine Pyruvate Kinase Deficiency
por: Trobridge, Grant D., et al.
Publicado: (2013)